Persistent inflammation and T cell exhaustion in severe sepsis in the elderly

Critical Care

Volumn 18, Issue 3, 2014, Pages

  Inoue, Shigeaki ^a   Suzuki, Kodai ^b   Komori, Yukako ^a   Morishita, Yukiko ^a   Suzuki Utsunomiya, Kyoko ^a   Hozumi, Katsuto ^a   Inokuchi, Sadaki ^a   Sato, Takehito ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; SERUM ALBUMIN;

ADOLESCENT; ADULT; AGED; ANIMAL; BLOOD; C57BL MOUSE; CELL COUNT; DISEASE MODEL; FEMALE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INFLAMMATION; LEUKOCYTE COUNT; LYMPHOCYTE ACTIVATION; MACROPHAGE; MALE; METABOLISM; MIDDLE AGED; NEUTROPHIL; PROSPECTIVE STUDY; SEPSIS; T LYMPHOCYTE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANIMALS; CELL COUNT; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNE TOLERANCE; INFLAMMATION; LEUKOCYTE COUNT; LYMPHOCYTE ACTIVATION; MACROPHAGES; MALE; MICE, INBRED C57BL; MIDDLE AGED; NEUTROPHILS; PROSPECTIVE STUDIES; SEPSIS; SERUM ALBUMIN; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84905040757     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13941     Document Type: Article

References (41)

1. Deans KJ, Haley M, Natanson C, Eichacker PQ, Minneci PC. Novel therapies for sepsis: a review. J Trauma 2005, 58:867-874.
2. Riedemann NC, Guo RF, Ward PA. The enigma of sepsis. J Clin Invest 2003, 112:460-467.
3. Keel M, Trentz O. Pathophysiology of polytrauma. Injury 2005, 36:691-709.
4. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2001, 2003:1250-1256.
5. Oberholzer A, Oberholzer C, Moldawer LL. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 2001, 16:83-96.
6. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348:138-150.
7. Bone RC. Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 1992, 268:3452-3455.
8. Schefold JC, Hasper D, Reinke P, Monneret G, Volk HD. Consider delayed immunosuppression into the concept of sepsis. Crit Care Med 2008, 36:3118.
9. Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, Bricker TL, Jarman Ii SD, Kreisel D, Krupnick AS, Srivastava A, Swanson PE, Green JM, Hotchkiss RS. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 2011, 306:2594-2605.
10. Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, Gao H, Hayden DL, Hennessy L, Moore EE, Minei JP, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Brownstein BH, Mason PH, Baker HV, Finnerty CC, Jeschke MG, Lopez MC, Klein MB, Gamelli RL, Gibran NS, Arnoldo B, Xu W, Zhang Y, Calvano SE, McDonald-Smith GP, et al. A genomic storm in critically injured humans. J Exp Med 2011, 208:2581-2590.
11. Gentile LF, Cuenca AG, Efron PA, Ang D, Bihorac A, McKinley BA, Moldawer LL, Moore FA. Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg 2012, 72:1491-1501.
12. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310.
13. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546-1554.
14. Martin GS, Mannino DM, Moss M. The effect of age on the development and outcome of adult sepsis. Crit Care Med 2006, 34:15-21.
15. Inoue S, Suzuki-Utsunomiya K, Okada Y, Iida Y, Taira T, Miura N, Tsuji T, Yamagiwa T, Morita S, Chiba T, Sato T, Inokuchi S. Reduction of immunocompetent T cells followed by prolonged lymphopenia in severe sepsis in the elderly. Crit Care Med 2013, 41:810-819.
16. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327.
17. Goronzy JJ, Weyand CM. Rheumatoid arthritis. Immunol Rev 2005, 204:55-73.
18. Chaudry IH, Wichterman KA, Baue AE. Effect of sepsis on tissue adenine nucleotide levels. Surgery 1979, 85:205-211.
19. Inoue S, Unsinger J, Davis CG, Muenzer JT, Ferguson TA, Chang K, Osborne DF, Clark AT, Coopersmith CM, McDunn JE, Hotchkiss RS. IL-15 prevents apoptosis, reverses innate and adaptive immune dysfunction, and improves survival in sepsis. J Immunol 2010, 184:1401-1409.
20. Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA. The sepsis seesaw: tilting toward immunosuppression. Nat Med 2009, 15:496-497.
21. Sriskandan S, Altmann DM. The immunology of sepsis. J Pathol 2008, 214:211-223.
22. Monneret G, Venet F, Pachot A, Lepape A. Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med 2008, 14:64-78.
23. Gallimore A, Glithero A, Godkin A, Tissot AC, Pluckthun A, Elliott T, Hengartner H, Zinkernagel R. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J Exp Med 1998, 187:1383-1393.
24. Zajac AJ, Blattman JN, Murali-Krishna K, Sourdive DJ, Suresh M, Altman JD, Ahmed R. Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 1998, 188:2205-2213.
25. Salek-Ardakani S, Schoenberger SP. T cell exhaustion: a means or an end?. Nat Immunol 2013, 14:531-533.
26. Yi JS, Cox MA, Zajac AJ. T-cell exhaustion: characteristics, causes and conversion. Immunology 2010, 129:474-481.
27. Chang K, Svabek C, Vazquez-Guillamet C, Sato B, Rasche D, Wilson S, Robbins P, Ulbrandt N, Suzich J, Green J, Patera AC, Blair W, Krishnan S, Hotchkiss R. Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Crit Care 2014, 18:R3.
28. Wherry EJ. T cell exhaustion. Nat Immunol 2011, 12:492-499.
29. Guignant C, Lepape A, Huang X, Kherouf H, Denis L, Poitevin F, Malcus C, Chéron A, Allaouchiche B, Gueyffier F, Ayala A, Monneret G, Venet F. Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. Crit Care 2011, 15:R99.
30. Alignani D, Maletto B, Liscovsky M, Ropolo A, Moron G, Pistoresi-Palencia MC. Orally administered OVA/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice. J Leukoc Biol 2005, 77:898-905.
31. Chen J, Wang J, Li J, Wu Q, Chu Lim F, Yang P, Hsu HC, Curiel DT, Mountz JD. Enhancement of cytotoxic T-lymphocyte response in aged mice by a novel treatment with recombinant AdIL-12 and wild-type adenovirus in rapid succession. Mol Ther 2008, 16:1500-1506.
32. Hsu HC, Shi J, Yang P, Xu X, Dodd C, Matsuki Y, Zhang HG, Mountz JD. Activated CD8(+) T cells from aged mice exhibit decreased activation-induced cell death. Mech Ageing Dev 2001, 122:1663-1684.
33. Smith P, Dunne DW, Fallon PG. Defective in vivo induction of functional type 2 cytokine responses in aged mice. Eur J Immunol 2001, 31:1495-1502.
34. Tateda K, Matsumoto T, Miyazaki S, Yamaguchi K. Lipopolysaccharide-induced lethality and cytokine production in aged mice. Infection & Immunity 1996, 64:769-774.
35. Murciano C, Villamon E, Yanez A, O'Connor JE, Gozalbo D, Gil ML. Impaired immune response to Candida albicans in aged mice. J Med Microbiol 2006, 55:1649-1656.
36. Park HR, Jo SK. Lasting effects of an impairment of Th1-like immune response in gamma-irradiated mice: A resemblance between irradiated mice and aged mice. Cell Immunol 2011, 267:1-8.
37. Park HR, Jo SK, Jung U, Yee ST. Restoration of the immune functions in aged mice by supplementation with a new herbal composition, HemoHIM. Phytother Res 2008, 22:36-42.
38. Kovacs EJ, Duffner LA, Plackett TP. Immunosuppression after injury in aged mice is associated with a TH1-TH2 shift, which can be restored by estrogen treatment. Mech Ageing Dev 2004, 125:121-123.
39. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, Finnerty CC, Lopez CM, Honari S, Moore EE, Minei JP, Cuschieri J, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Jeschke MG, Klein MB, Gamelli RL, Gibran NS, Brownstein BH, Miller-Graziano C, Calvano SE, Mason PH, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA 2013, 110:3507-3512.
40. Inoue S, Sato T, Suzuki-Utsunomiya K, Komori Y, Hozumi K, Chiba T, Yahata T, Nakai K, Inokuchi S. Sepsis-induced hypercytokinemia and lymphocyte apoptosis in aging-accelerated Klotho knockout mice. Shock 2013, 39:311-316.
41. Zhang N, Ahsan MH, Zhu L, Sambucetti LC, Purchio AF, West DB. Regulation of IkappaBalpha expression involves both NF-kappaB and the MAP kinase signaling pathways. J Inflamm (Lond) 2005, 2:10.